Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 0 | 940 | 1,032 | 1,332 | 1,444 |
| Cost of Goods | N/A | 370 | 343 | 879 | 714 |
| Gross Profit | N/A | 570 | 689 | 453 | 731 |
| Operating Expenses | 11,781 | 6,756 | 17,243 | 13,764 | 8,791 |
| Operating Income | -11,781 | -5,817 | -16,210 | -12,432 | -7,346 |
| Interest Expense | 77 | 4 | 18 | 656 | 332 |
| Other Income | 18 | 31 | 159 | -3 | 0 |
| Pre-tax Income | -11,840 | -5,790 | -16,069 | -13,091 | -7,679 |
| Net Income Continuous | -11,840 | -5,790 | -16,069 | -13,091 | -7,679 |
| Net Income | $-11,840 | $-5,790 | $-16,069 | $-13,091 | $-7,679 |
| EPS Basic Total Ops | -5,754.26 | -2,877.13 | -10,069.95 | -13,306.72 | -24,095.95 |
| EPS Basic Continuous Ops | -5,808.30 | -2,879.56 | -10,040.28 | -13,272.05 | -24,148.62 |
| EPS Diluted Total Ops | -5,754.26 | -2,877.13 | -10,069.95 | -13,306.72 | -24,095.95 |
| EPS Diluted Continuous Ops | -5,808.30 | -2,879.56 | -10,040.28 | -13,272.05 | -24,148.62 |
| EBITDA(a) | $-11,710 | $-5,789 | $-16,134 | $-12,357 | $-7,267 |